A biotechnology venture capital firm is ringing in the new year with its latest fund, having raised a quarter of $1 billion.
Cambridge, Massachusetts-based Atlas Venture said Wednesday that it closed its first Opportunity Fund, or AVOF I, with an oversubscribed fund raise of $250 million. The firm plans to invest the money in companies already in its portfolio.
{iframe}https://medcitynews.com/2019/01/atlas-venture-raises-250m-for-opportunity-fund/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=68716721&_hsenc=p2ANqtz-_VCQR00pCU5Dh3Yt_GJRtZBa8Od1XlP7driWIfSu_4ih6RAyde9jQincJkmGptDN6lTN6Cbj8mMtJMDzPfgK9HHf-0Aw&_hsmi=68716721{/iframe}